Literature DB >> 548995

Postprandial serum creatinine increase in normal subjects after eating cooked meat.

F K Jacobsen, C K Christensen, C E Mogensen, F Andreasen, N S Heilskov.   

Abstract

Ingestion of meals containing cooked meat caused a marked postprandial increase in serum creatinine concentration, whereas ingestion of raw meat had no effect on serum creatinine. A peak mean value was seen 3 hours after the start of meals. No change in creatinine clearance was observed. Analysis of serum creatinine by conventional autoanalyser and by an ion exchange method ('true creatinine") showed a high degree of correlation, making a possible effect of non-creatinine chromogens unlikely. It was shown that creatinine is produced from creatine when meat is boiled.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 548995

Source DB:  PubMed          Journal:  Proc Eur Dial Transplant Assoc        ISSN: 0071-2736


  4 in total

1.  The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Csaba P Kovesdy; Antigone Oreopoulos; Nazanin Noori; Jennie Jing; Allen R Nissenson; Mahesh Krishnan; Joel D Kopple; Rajnish Mehrotra; Stefan D Anker
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

2.  Effect of Diet on Serum Creatinine in Healthy Subjects During a Phase I Study.

Authors:  Eduardo Pimenta; Markus Jensen; David Jung; Frank Schaumann; Stefanie Boxnick; Hubert Truebel
Journal:  J Clin Med Res       Date:  2016-09-29

3.  Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers.

Authors:  Thomas Schluep; Jason Lickliter; James Hamilton; David L Lewis; Ching-Lung Lai; Johnson Yn Lau; Stephen A Locarnini; Robert G Gish; Bruce D Given
Journal:  Clin Pharmacol Drug Dev       Date:  2016-12-12

4.  Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

Authors:  Aili L Lazaar; Lucy Yang; Rebecca L Boardley; Navin S Goyal; Jonathan Robertson; Sandra J Baldwin; David E Newby; Ian B Wilkinson; Ruth Tal-Singer; Ruth J Mayer; Joseph Cheriyan
Journal:  Br J Clin Pharmacol       Date:  2016-01-17       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.